Free Trial
NASDAQ:ALAB

Astera Labs (ALAB) Stock Price, News & Analysis

Astera Labs logo
$163.12 +1.66 (+1.03%)
As of 12:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Astera Labs Stock (NASDAQ:ALAB)

Advanced

Key Stats

Today's Range
$159.80
$167.41
50-Day Range
$161.46
$251.88
52-Week Range
$47.13
$262.90
Volume
2.60 million shs
Average Volume
5.21 million shs
Market Capitalization
$27.18 billion
P/E Ratio
293.57
Dividend Yield
N/A
Price Target
$159.83
Consensus Rating
Moderate Buy

Company Overview

Astera Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

ALAB MarketRank™: 

Astera Labs scored higher than 62% of companies evaluated by MarketBeat, and ranked 345th out of 673 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Astera Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.65, and is based on 15 buy ratings, 8 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Astera Labs is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Astera Labs has been the subject of 17 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Astera Labs' stock forecast and price target.
  • Earnings Growth

    Earnings for Astera Labs are expected to grow by 117.65% in the coming year, from $0.34 to $0.74 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Astera Labs is 295.01, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 233.71.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Astera Labs is 295.01, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 492.53.

  • Price to Earnings Growth Ratio

    Astera Labs has a PEG Ratio of 4.03. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Astera Labs has a P/B Ratio of 27.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Astera Labs' valuation and earnings.
  • Percentage of Shares Shorted

    7.56% of the float of Astera Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Astera Labs has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Astera Labs has recently increased by 4.45%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Astera Labs does not currently pay a dividend.

  • Dividend Growth

    Astera Labs does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.56% of the float of Astera Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Astera Labs has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Astera Labs has recently increased by 4.45%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Astera Labs has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 23 news articles for Astera Labs this week, compared to 22 articles on an average week.
  • Search Interest

    173 people have searched for ALAB on MarketBeat in the last 30 days. This is an increase of 71% compared to the previous 30 days.
  • MarketBeat Follows

    85 people have added Astera Labs to their MarketBeat watchlist in the last 30 days. This is an increase of 98% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Astera Labs insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $214,482,678.00 in company stock.

  • Percentage Held by Insiders

    12.50% of the stock of Astera Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    60.47% of the stock of Astera Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Astera Labs' insider trading history.
Receive ALAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Astera Labs and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALAB Stock News Headlines

Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
Astera Labs falls -12.7%
See More Headlines

ALAB Stock Analysis - Frequently Asked Questions

Astera Labs' stock was trading at $132.45 on January 1st, 2025. Since then, ALAB shares have increased by 24.6% and is now trading at $165.0560.

Astera Labs, Inc. (NASDAQ:ALAB) announced its quarterly earnings results on Tuesday, August, 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The company's quarterly revenue was up 149.5% on a year-over-year basis.
Read the conference call transcript
.

Astera Labs (ALAB) raised $713 million in an IPO on Wednesday, March 20th 2024. The company issued 19,800,000 shares at a price of $36.00 per share.

Astera Labs' top institutional investors include Pacer Advisors Inc. (0.31%), Voya Investment Management LLC (0.20%), Salem Investment Counselors Inc. (0.11%) and Oriental Harbor Investment Master Fund (0.04%). Insiders that own company stock include Jitendra Mohan, Sanjay Gajendra, Manuel Alba, Michael Truett Tate, Philip Mazzara, Stefan A Dyckerhoff, Jack R Lazar, Michael E Hurlston and Bethany Mayer.
View institutional ownership trends
.

Shares of ALAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Astera Labs investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), Advanced Micro Devices (AMD), Meta Platforms (META) and Tesla (TSLA).

Company Calendar

Last Earnings
8/05/2025
Today
10/16/2025
Next Earnings (Estimated)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
INTERNET SOFTWARE
Sub-Industry
Electronic Equipment
Current Symbol
NASDAQ:ALAB
Previous Symbol
NASDAQ:ALAB
CIK
1736297
Fax
N/A
Employees
225
Year Founded
2017

Price Target and Rating

High Price Target
$275.00
Low Price Target
$82.00
Potential Upside/Downside
-1.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.65
Research Coverage
23 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.56
Trailing P/E Ratio
288.32
Forward P/E Ratio
474.88
P/E Growth
4.03
Net Income
-$83.42 million
Net Margins
16.54%
Pretax Margin
14.05%
Return on Equity
9.53%
Return on Assets
8.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.10
Quick Ratio
10.55

Sales & Book Value

Annual Sales
$605.55 million
Price / Sales
44.32
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.08 per share
Price / Book
26.56

Miscellaneous

Outstanding Shares
166,219,000
Free Float
145,442,000
Market Cap
$26.84 billion
Optionable
Optionable
Beta
1.43

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:ALAB) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners